Immunovant (IMVT) Net Cash Flow (2019 - 2026)
Immunovant's Net Cash Flow came in at -$104.31 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$114.49 million a year earlier.
Powered by 
Analysis
Immunovant (IMVT) Net Cash Flow (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Immunovant reported Net Cash Flow of $198.62 million, up 408.5% year-over-year; for FY2026 (ended Mar 31, 2026), it was $188.44 million, up 142.0% from FY2025.
- Net Cash Flow carries a five-year compound annual growth rate of -8.9% (FY2021 to FY2026).
- Going back by fiscal year, Net Cash Flow was $77.86 million in FY2025 (-69.8%), $257.84 million in FY2024, -$117.51 million in FY2023 and $93.76 million in FY2022 (-68.7%).
- The five-year range for quarterly Net Cash Flow is -$114.49 million (fiscal Q1 2026) to $472.28 million (fiscal Q3 2026).
- Business Quant data shows IMVT's Net Cash Flow at -$91.43 million (Q4 2026), $472.28 million (Q3 2026) and -$77.92 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.71 Bn | 1,105.29 Bn | 19.71 Bn | 3.72 Bn |
| 2 | Johnson & Johnson | 617.55 Bn | 536.07 Bn | 17.26 Bn | -1.27 Bn |
| 3 | AbbVie | 501.02 Bn | 474.13 Bn | 12.70 Bn | -2.82 Bn |
| 4 | Merck | 368.18 Bn | 322.56 Bn | 12.21 Bn | 1.53 Bn |
| 5 | Novartis Ag | 297.89 Bn | 261.88 Bn | 11.24 Bn | 757.00 Mn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn | -3.94 Bn |
| 7 | Amgen | 236.60 Bn | 191.99 Bn | 7.24 Bn | 1.95 Bn |
| 8 | Gilead Sciences | 190.55 Bn | 164.75 Bn | 6.22 Bn | -4.43 Bn |
| 9 | Pfizer | 169.77 Bn | 116.42 Bn | 10.94 Bn | -722.00 Mn |
| 10 | Immunovant | 5.81 Bn | 2.59 Bn | - | -104.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -104.31 Mn |
| Mar 31, 2026 | -91.43 Mn |
| Dec 31, 2025 | 472.28 Mn |
| Sep 30, 2025 | -77.92 Mn |
| Jun 30, 2025 | -114.49 Mn |
| Mar 31, 2025 | 339.77 Mn |
| Dec 31, 2024 | -98.11 Mn |
| Sep 30, 2024 | -88.11 Mn |
| Jun 30, 2024 | -75.70 Mn |
| Mar 31, 2024 | -58.30 Mn |
| Dec 31, 2023 | 422.62 Mn |
| Sep 30, 2023 | -59.95 Mn |
| Jun 30, 2023 | -46.53 Mn |
| Mar 31, 2023 | -55.59 Mn |
| Dec 31, 2022 | 24.14 Mn |
| Sep 30, 2022 | -20.22 Mn |
| Jun 30, 2022 | -65.84 Mn |
| Mar 31, 2022 | -33.07 Mn |
| Dec 31, 2021 | -31.97 Mn |
| Sep 30, 2021 | 179.95 Mn |
API Access
Immunovant Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();